Barclays

Barclays’s Vera Therapeutics VERA Stock Holding History

Barclays’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.35M	Sell	232,516 -21,200	-8%	-$913K	﹤0.01%	1486
2025 Q4	$12.8M	Buy	253,716 +36,123	+17%	+$1.28M	0.01%	1505
2025 Q3	$6.32M	Buy	217,593 +6,716	+3%	+$155K	﹤0.01%	2014
2025 Q2	$4.97M	Buy	210,877 +121,161	+135%	+$2.72M	﹤0.01%	2143
2025 Q1	$2.15M	Sell	89,716 -9,432	-10%	-$303K	﹤0.01%	2574
2024 Q4	$4.19M	Buy	99,148 +13,753	+16%	+$609K	﹤0.01%	2320
2024 Q3	$3.77M	Buy	85,395 +41,394	+94%	+$1.57M	﹤0.01%	2320
2024 Q2	$1.59M	Buy	44,001 +433	+1%	+$17.2K	﹤0.01%	2298
2024 Q1	$1.88M	Sell	43,568 -70,179	-62%	-$2.5M	﹤0.01%	2622
2023 Q4	$1.75M	Buy	113,747 +42,044	+59%	+$534K	﹤0.01%	3026
2023 Q3	$983K	Buy	71,703 +64,968	+965%	+$1.11M	﹤0.01%	2351
2023 Q2	$108K	Sell	6,735 -4,237	-39%	-$38.3K	﹤0.01%	3524
2023 Q1	$85.1K	Sell	10,972 -2,307	-17%	-$17.8K	﹤0.01%	4266
2022 Q4	$257K	Buy	13,279 +3,254	+32%	+$58.9K	﹤0.01%	3709
2022 Q3	$214K	Buy	10,025 +9,329	+1,340%	+$175K	﹤0.01%	3158
2022 Q2	$9K	Sell	696 -1,526	-69%	-$26.6K	﹤0.01%	4669
2022 Q1	$53K	Buy	+2,222	New	+$47.8K	﹤0.01%	4101

Other funds holding VERA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return